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Abstract X-band electron spin resonance spectroscopy was used 
to study the binding of vanadium (IV), or vanadyl, to the brain 
serine/threonine phosphatase-2B, caicineurin. Spectra were de- 
termined on frozen solutions of vanadyl and caicineurin at pH 7.4 
in the presence of 20% (v/v) glycerol. The binding of vanadyl to 
the enzyme was established, and the data suggested the presence 
of two classes of sites, the higher affinity class of which contained 
two binding sites for vanadyl. The calcium-binding B subunit of 
the heterodimeric protein was also shown to bind vanadyl. The 
holoprotein appeared to be stabilized by vanadyl, and vanadyl 
enhanced enzymatic activity when assayed with or without cal- 
modulin in the absence of calcium. 
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Vanadium, an essential trace element in experimental ni- 
mals [9], mimics many of the actions of insulin [10] and may 
have clinical potential for the treatment of diabetes and insulin 
resistance [11]. It is found in vivo primarily in its V oxidation 
state, vanadate; in turn, this is reduced intracellulary to the IV 
oxidation state, vanadyl [12]. ESR spectroscopy has been used 
to demonstrate hat vanadyl binds to a variety of metallopro- 
teins [13,14]. We have shown that vanadyl binds to calmodulin 
[15,16] and inhibits the stimulation of skeletal muscle myosin 
light chain kinase activity [17]. In view of the homology of the 
calcineurin B subunit and calmodulin, particularly in the re- 
gions of calcium-binding [1], we performed ESR spectroscopy 
to ascertain if vanadyl binds to brain calcineurin. Our results 
show that vanadyl binds to this protein phosphatase and ap- 
pears to enhance nzymatic activity. 
1. Introduction 
The important serine/threonine protein phosphatase-2B, cal- 
cineurin, exists as a heterodimer and requires metal ions and 
calmodulin for full enzymatic activity [1]. The A subunit (Mr 
61 kDa) contains the catalytic site and binding region for cal- 
modulin; the B subunit (Mr 19 kDa) contains four calcium- 
binding sites in the form of 'EF hands' and exhibits homology 
with calmodulin and troponin C [1]. Genomic and complemen- 
tary DNA sequences are available for the A and B subunits 
from several species and indicate a high degree of conservation 
of structure during evolution [24]. 
Of considerable interest were the findings that two structur- 
ally unrelated immunosuppressants that inhibit T lymphocyte 
activation and lymphokine production, cyclosporin A and 
FK506, both of which are derived from mold fermentation 
broths and bind respectively to cyclophilin and FK  binding 
protein, i.e. immunophilins, inhibit calcineurin activity [5,6]. 
Recent studies have shown that a target protein of calcineurin 
is the nuclear factor of activated T cells, NF-AT, a phos- 
phorylated transcriptional ctivator of the interleukin-2 gene 
[7,8]. 
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2. Experimental 
2.1. Preparation of calcineurin/subunits andenzymatic assay 
Calcineurin was purified to homogeneity from bovine brain by am- 
monium sulfate precipitation followed by column chromatography: 
DE-52 cellulose, Affi-gel-Blue, calmodulin-Sepharose 4B (affinity), and 
Sephacryl 200 [18,19]. Subunits were prepared by dialyzing calcineurin 
against 6M urea for 4-6 h in a buffer containing 0.1 M HEPES, 5 mM 
dithiothreitol, 15 mM EDTA, and 80 mM LiBr, pH 7.4, followed by 
chromatography on a DEAE-Sephadex CL-6B column which resolved 
the two subunits. Metal ions were removed from the B subunit fraction, 
and this was concentrated with a Centricon 10 column (Amicon). Cal- 
cineurin activity was determined as described by Li [20] after dilution 
in 50 mM Tris-HCl, pH 7.4, 0.5 mM dithiothreitol, 0.2 mg/ml bovine 
serum albumin. The assay solution contained 20 mM p-nitrophenyl 
phosphate, 0.1 mM CaC12, 0.5 mM MnCI2, and 0.3/.tM calmodulin. 
2.2. ESR spectroscopy 
X-band (9.2 GHz) ESR spectra were measured using an IBM-Bruker 
(ER-200 SRC) ESR spectrometer quipped with an IBM-9000 com- 
puter and a dual TEj04 cavity. Repetitive scans, typically 5-7, were 
stored, and the data were subjected to standard signal averaging and 
baseline corrections. Spectra were obtained on liquid (298 K) and fro- 
zen (125 K) solutions. However, since calcineurin appeared unstable for 
long periods of time at 298 K and since the concentration f each 
sample was low, higher sensitivity was achieved by freezing the samples 
which yielded spectra near the rigid limit. Stock vanadyl solutions of 
about 0.1 M were prepared by dissolving vanadyl sulfate in deionized, 
doubly distilled water and adjusting the pH to 2 with 6 N HCI. The 
solutions were degassed, and exact concentrations were determined 
spectrophotometrically at 750 nm using an extinction coefficient of 18 
M- ~ • cm-' [21 ]. Aliquots of the vanadyl stock solution were titrated into 
protein solutions (ca. 0.1 mM calcineurin 0.15 ml of 0.1 M HEPES, 
pH 7.4, 0.1 M NaC1, and 0.5 mM dithiothreitol), which had been 
purged with N2, under constant stirring. After 5 min of additional 
stirring, the solutions were transferred toquartz capillary tubes (3 mm 
o.d., Wilmad), sealed with paraffin tape, and cooled in a dry ice-acetone 
bath. The sample was then placed in one of the ESR cavities; the other 
cavity contained 1mM VOSO4 in 20% aqueous glycerol, pH 2, in a 
quartz fiat cell as a concentration standard. The temperature was con- 
trolled at 125 K with a Bruker ER 4111 VT. 
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F~g. 1. ESR spectra of: (a) vanadyl at pH 2 and 125 K in the presence 
o! 20% glycerol (v/v), and (b) of vanadyl/calcineurin (8:1 molar equiv- 
alents) at pH 7.4 and 125 K in the presence of 20% (v/v) glycerol (the 
h~gh field and second low field resonance peaks are amplified). 
3 Results and discussion 
The ESR spectra of vanadyl at 125 K (pH 2) and of vanadyl/ 
c,tlcineurin (8 : 1 molar ratio) at 125 K (pH 7.4) are shown in 
[ig. la and lb, respectively. Since vanadyl is ESR silent at pH 
7 4, the spectrum obtained in the presence of protein is indica- 
t ve of vanadyl binding to the phosphatase and differs consider- 
a 91y from that of free vanadyl. A splitting of the second low 
fi eld resonance is apparent, and, in addition, the high field and 
crater peaks are skewed (Fig. lb). These findings are suggestive 
( f  at least two classes of binding sites. 
The intensity of the vanadyl center peak was determined at 
x arious molar ratios of vanadyl:calcineurin u der the same 
c 9nditions (Fig. 2). Calcineurin is relatively unstable, and thus 
~1 fresh aliquot of protein was used for each vanadyl equivalent; 
t he utilization of the dual cavity technique nabled us to obtain 
considerable r lative accuracy. Assay of the enzyme following 
r,:cording of the ESR spectra showed that 90% of the activity 
was recovered. The center peak intensity increased in an ap- 
proximate linear fashion upon addition of the first two vanadyl 
equivalents, then there was no change in signal between the 
addition of the third and fifth equivalents, and finally a small 
increase in intensity was observed as additional vanadyl was 
added to a final vanadyl/enzyme ratio of 8 : 1. These results are 
consistent with the presence of two classes of vanadyl sites on 
calcineurin. When two equivalents of calcium were added to 
calcineurin, followed by the addition of two equivalents of 
vanadyl, the appearance of an ESR spectrum (not shown) indi- 
cated that calcium and vanadyl bind to distinct sites on the 
phosphatase or that vanadyl has a higher affinity than calcium 
for the first two metal binding sites. 
Since only very limited amounts of purified subunits were 
available, we were unable to obtain definitive ESR spectra of 
vanadyl and the A and B subunits. A preliminary spectrum is 
shown in Fig. 3 for the B subunit with 6 equivalents of vanadyl 
(125 K, pH 7.4). The spectrum exhibits near 'rigid limit' prop- 
erties and is similar to that of vanadyl with the holoprotein. 
Yet, differences do exist, probably attributable to binding of 
vanadyl to the A subunit or perhaps to subunit conformational 
changes associated with heterodimer formation that affects 
binding. 
In view of the apparent stabilization of calcineurin by 
vanadyl, enzymatic activity was measured in the presence of 
vanadyl (Fig. 4). Of considerable interest was the finding that 
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Fig. 2. Normalized center field peak intensity of vanadyl at various 
vanadyl/calcineurin molar ratios at pH 7.4, 125 K in the presence of 
20% (v/v) glycerol. Each point represents a fresh aliquot of protein. 
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Fig. 3. ESR spectrum of vanadyl in the presence of the calcineurin B
subunit at a molar atio of6:1 (pH 7.4, 125 K) in the presence of 20% 
(v/v) glycerol. 
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Fig. 4. Effect of vanadyl on calcineurin activity, which was assayed 
using p-nitrophenyl phosphate as a substrate, Calcium and vanadyl 
were present at 0.1 mM where added. 
vanadyl eads to higher enzymatic activity than does calcium, 
a finding that was consistently observed in several independent 
assays under slightly varying conditions. Moreover, increased 
calcineurin activity was noted under comparable assay condi- 
tions, but in the absence of calcium and calmodulin (data not 
shown). Thus, vanadyl can interact directly with the A or B 
subunit, or both, and enhance enzymatic activity. We have 
shown that vanadyl also binds to calmodulin [15,16], although 
the vanadyl-calmodulin complex does not stimulate skeletal 
muscle myosin light chain kinase activity [17], as does calcium- 
calmodulin. A role of vanadyl-calmodulin in calcineurin regula- 
tion could not be directly determined since vanadyl is capable 
of directly enhancing enzymatic activity. 
In summary, this study has demonstrated that vanadyl binds 
to calcineurin and can stimulate nzymatic activity in the ab- 
sence of calcium and calmodulin. 
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